BUCKS COUNTY, PA — A "catastrophic" explosion at a nursing home just outside of Philadelphia killed at least two people, injured 20 others, and left the facility partially collapsed on Tuesday, ...

KPRC 2 witnessed a large law enforcement and first responder presence near the base of the causeway bridge in Galveston as authorities responded. Thick fog on Galveston Causeway (Houston Transtar) ...

Want to master data fitting in Python? 📊🐍 In this video, we’ll walk you through using the least squares method to fit data and graph it using Python. Perfect for data science and stats enthusiasts! ...

Phase III is intended to generate meaningful biological data on potential drug compounds prioritized by YuvaBio’s classifier, which applies proprietary machine-learning methods to identify candidates ...

During a roundtable discussion with Commerce Secretary Howard Lutnick and tech business leaders, Trump announced that the website for the program would soon be live for people to look at and sign up ...

Three people were arrested at a City of Port Washington meeting Dec. 2 where protesters spoke out against a $15 billion artificial intelligence data center campus for tech giants OpenAI and Oracle.

A pair of educators at Boylston Elementary School were arrested last week and charged with assaulting multiple children on Nov. 21 at an after-school program, according to a police report. Benjamin ...

Tax increment financing, or TIF, is an economic tool that uses new tax revenue from a project to help pay for its construction. Louisville has approved over 30 TIFs since the early 2000s, directing at ...

Next year, booklovers at UC Santa Barbara (UCSB) will be encouraged to read “Crying in H Mart,” a bestselling memoir about cultural identity and grief, the university announced this week. The ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) on Thursday shared topline data from its Phase 2 VISTA trial of PIPE-307, an M1 receptor antagonist for relapsing-remitting multiple sclerosis (RRMS). RRMS ...

A groundbreaking new trial is set to investigate whether an mRNA jab, designed to target the Epstein-Barr virus (EBV), could offer a novel treatment pathway for multiple sclerosis (MS). Scientists are ...